Enabled by WuXi Biologics’ industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to commercialization.Velaglucerase-beta for injection, as the first and the only locally developed enzyme replacement therapy (ERT) for Gaucher disease in China, marks a significant…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, FUBO, RKDA, NSC on Behalf of Shareholders
NEW YORK, Aug. 1, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: